Intracellular transport and peptide binding properties of HLA class II glycoproteins. 1990

P Cresswell, and R R Avva, and J E Davis, and C A Lamb, and J M Riberdy, and P A Roche
Division of Immunology, Duke University Medical Center, Durham, NC 27710.

Protein antigens internalized by an antigen presenting cell are degraded into peptides, a subset of which binds to the class II glycoproteins encoded by the major histocompatibility complex to form epitopes recognized by specific T cells. Current evidence suggests that the immunogenic peptides are generated in an endosomal, acidic compartment containing internalized antigen, proteinases, and exocytic class II molecules. These exocytic class II glycoproteins are associated during transport from the endoplasmic reticulum to the endosomal compartment with an additional glycoprotein, the invariant chain. Proteolytic degradation of the invariant chain in the endosomal compartment dissociates it from the class II glycoproteins, which only then acquire the capacity to bind peptides. After peptide binding occurs, the class II-peptide complexes are transported to the antigen-presenting cell surface for recognition by T cells.

UI MeSH Term Description Entries
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004705 Endocytosis Cellular uptake of extracellular materials within membrane-limited vacuoles or microvesicles. ENDOSOMES play a central role in endocytosis. Endocytoses
D005089 Exocytosis Cellular release of material within membrane-limited vesicles by fusion of the vesicles with the CELL MEMBRANE.
D006681 HLA-D Antigens Human immune-response or Class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology. Antigens, HLA-D,Class II Human Antigens,HLA-Dw Antigens,Human Class II Antigens,Ia-Like Antigens, Human,Immune Response-Associated Antigens, Human,Immune-Associated Antigens, Human,Immune-Response Antigens, Human,HLA-D,HLA-Dw,Immune Response Associated Antigens, Human,Antigens, HLA D,Antigens, HLA-Dw,Antigens, Human Ia-Like,Antigens, Human Immune-Associated,Antigens, Human Immune-Response,HLA D Antigens,HLA Dw Antigens,Human Ia-Like Antigens,Human Immune-Associated Antigens,Human Immune-Response Antigens,Ia Like Antigens, Human,Immune Associated Antigens, Human,Immune Response Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001693 Biological Transport, Active The movement of materials across cell membranes and epithelial layers against an electrochemical gradient, requiring the expenditure of metabolic energy. Active Transport,Uphill Transport,Active Biological Transport,Biologic Transport, Active,Transport, Active Biological,Active Biologic Transport,Transport, Active,Transport, Active Biologic,Transport, Uphill
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

P Cresswell, and R R Avva, and J E Davis, and C A Lamb, and J M Riberdy, and P A Roche
January 1990, Immunologic research,
P Cresswell, and R R Avva, and J E Davis, and C A Lamb, and J M Riberdy, and P A Roche
February 2002, Tissue antigens,
P Cresswell, and R R Avva, and J E Davis, and C A Lamb, and J M Riberdy, and P A Roche
January 1997, Advances in immunology,
P Cresswell, and R R Avva, and J E Davis, and C A Lamb, and J M Riberdy, and P A Roche
January 1997, Biopolymers,
P Cresswell, and R R Avva, and J E Davis, and C A Lamb, and J M Riberdy, and P A Roche
March 2009, Human immunology,
P Cresswell, and R R Avva, and J E Davis, and C A Lamb, and J M Riberdy, and P A Roche
October 1994, Immunity,
P Cresswell, and R R Avva, and J E Davis, and C A Lamb, and J M Riberdy, and P A Roche
January 2019, Methods in molecular biology (Clifton, N.J.),
P Cresswell, and R R Avva, and J E Davis, and C A Lamb, and J M Riberdy, and P A Roche
April 1991, Proceedings of the National Academy of Sciences of the United States of America,
P Cresswell, and R R Avva, and J E Davis, and C A Lamb, and J M Riberdy, and P A Roche
June 1988, Proceedings of the National Academy of Sciences of the United States of America,
P Cresswell, and R R Avva, and J E Davis, and C A Lamb, and J M Riberdy, and P A Roche
January 1989, Immunogenetics,
Copied contents to your clipboard!